Alx Oncology Holdings 

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-191
-211
EBITDA
-23,021
-21,583
-25,353
-30,137
EBIT
-21,736
-25,544
-30,348
Net Income
-22,848
-22,144
-25,949
-30,754
Net Change In Cash
0
0
0
0
Free Cash Flow
-19,029
-17,149
-23,453
-24,723
Cash
16,373
23,442
19,302
20,614
Basic Shares
54,283
53,577
53,445
53,359

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-872
-836
-1,466
EBITDA
-100,846
-132,249
-158,404
-127,094
EBIT
-133,121
-159,240
-127,436
Net Income
-101,695
-134,850
-160,805
-123,482
Net Change In Cash
0
0
0
0
Cost of Revenue
-314,779
Free Cash Flow
-84,354
-122,359
-131,638
-90,650
Cash
16,373
17,567
22,406
48,822
Basic Shares
53,658
52,174
42,987
40,699

Earnings Calls

QuarterEPS
2025-12-31
-$0.36
2025-09-30
-$0.41
2025-06-30
-$0.49
2025-03-31
-$0.47